Scholarly Index
Otto Metzger
Dana-Farber Cancer Institute; 8,785 total citations; 229 total publications; best world rank #120
Dana-Farber Cancer Institute
8,785Total citations
229Total publications
39H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Cancer Treatment Studies | Lifetime | 827 | US 370 | 97.72 |
| HER2/EGFR in Cancer Research | Lifetime | 785 | US 351 | 96.88 |
| Advanced Breast Cancer Therapies | Lifetime | 447 | US 209 | 96.46 |
| Breast Lesions and Carcinomas | Lifetime | 992 | US 435 | 94.28 |
| Breast Cancer Treatment Studies | 2021-2025 | 120 | US 43 | 98.45 |
| HER2/EGFR in Cancer Research | 2021-2025 | 232 | US 82 | 96.37 |
| Breast Lesions and Carcinomas | 2021-2025 | 170 | US 55 | 92.13 |
| Advanced Breast Cancer Therapies | 2021-2025 | 376 | US 141 | 93.14 |
| Cancer Treatment and Pharmacology | 2021-2025 | 483 | US 175 | 90.90 |
| Estrogen and related hormone effects | 2021-2025 | 578 | US 185 | 77.72 |